Veracyte (VCYT) Change in Receivables (2012 - 2026)

Veracyte has disclosed Change in Receivables across 15 years of filings, most recently posting $5.6 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at $5.6 million, down 21.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$778000.0 (down 111.12% YoY), and the FY2025 annual result was $708000.0, down 88.95% from the prior year.
• Change in Receivables came in at $5.6 million for Q1 2026 at Veracyte, up from -$3.2 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $7.1 million in Q1 2025 to a low of -$3.2 million in Q4 2025.
• The 5-year median for Change in Receivables is $139000.0 (2022), against an average of $781647.1.
• Peak annual rise in Change in Receivables reached 448.92% in 2023, while the deepest fall reached 383.72% in 2023.
• Veracyte's Change in Receivables stood at $139000.0 in 2022, then soared by 448.92% to $763000.0 in 2023, then sank by 360.94% to -$2.0 million in 2024, then slumped by 58.21% to -$3.2 million in 2025, then soared by 276.73% to $5.6 million in 2026.
• The last three Change in Receivables figures came in at $5.6 million (Q1 2026), -$3.2 million (Q4 2025), and -$425000.0 (Q3 2025), per Business Quant data.